{"hq_id":"hq-p-spe-000092","name":"Breast Implant (Silicone Gel Bleed, BIA-ALCL, FDA Black Box 2020)","category":{"primary":"specialty","secondary":"medical","tags":["breast implant","silicone","BIA-ALCL","lymphoma","FDA","black box","gel bleed"]},"product_tier":"SPE","overall_risk_level":"moderate","description":"Silicone gel and saline breast implants. FDA 2020: required black box warning and patient decision checklist for all breast implants. BIA-ALCL (breast implant-associated anaplastic large cell lymphoma): rare T-cell lymphoma associated primarily with textured implants (not smooth). Silicone gel bleed: small amounts of silicone molecules migrate through intact shell — long-term health significance debated. 'Breast implant illness' (BII): constellation of systemic symptoms reported by some patients, not formally recognized as a diagnosis.","synthesis":{"derived_risk_level":"moderate_to_high","synthesis_confidence":0.5,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":1.4,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"all breast implant recipients","overall_risk":"moderate","primary_concerns":["BIA-ALCL: rare lymphoma (733 cases, 36 deaths worldwide) — primarily textured implants","FDA black box warning required since 2020","Silicone gel bleed through intact shell (continuous low-level migration)","Implants NOT lifetime devices — 10-15 year average replacement"],"exposure_routes":"Continuous systemic exposure from implanted silicone device"},"exposure":{"routes":["dermal"],"contact_types":["skin_prolonged"],"users":["adult"],"duration":"continuous","frequency":"daily","scenarios":["Silicone gel bleed through intact shell (continuous low-level)","BIA-ALCL: rare lymphoma primarily associated with textured implants","Capsular contracture: scar tissue hardening around implant","FDA black box warning required since 2020"],"notes":"FDA 2020: black box warning + patient decision checklist for all breast implants. BIA-ALCL: 733 cases, 36 deaths worldwide (as of FDA 2021) — primarily textured implants. Allergan Biocell textured implant recalled (2019) after BIA-ALCL association. Smooth implants: dramatically lower BIA-ALCL risk. Implants are NOT lifetime devices — average 10-15 year replacement cycle. MRI recommended every 5-6 years for silicone implant integrity screening (FDA)."},"consumer_guidance":{"usage_warning":"Review FDA patient decision checklist before surgery. Understand: implants are NOT lifetime devices (10-15 year replacement). Choose smooth over textured (lower BIA-ALCL risk). Schedule MRI every 5-6 years for silicone implant screening (FDA recommendation). Report any breast changes to surgeon immediately.","safer_alternatives":["Smooth implants (lower BIA-ALCL risk than textured)","Saline implants (if silicone gel rupture is a concern — but less natural feel)","Fat transfer augmentation (autologous tissue — no implant)","Informed decision to not get implants (zero device risk)"],"red_flags":[{"indicator":"Health claims without FDA approval or clinical evidence","meaning":"Product efficacy unverified.","action":"Consult physician. Check FDA and clinical trial evidence."}],"green_flags":[{"indicator":"FDA-approved, USP-verified, or physician-recommended","meaning":"Verified safety and/or efficacy through established evaluation.","verification":"Check FDA approval status, USP mark, or published clinical evidence."}],"what_to_ask":[{"question":"Is there FDA-approved or peer-reviewed clinical evidence for this product?","why_it_matters":"Health products without evidence may be ineffective or harmful.","good_answer":"FDA-approved or supported by published RCTs.","bad_answer":"Testimonials only or DSHEA-exempt supplement with no clinical evidence."}],"alternatives":[{"name":"Smooth implants","notes":"lower BIA-ALCL risk than textured"},{"name":"Saline implants","notes":"if silicone gel rupture is a concern — but less natural feel"},{"name":"Fat transfer augmentation","notes":"autologous tissue — no implant"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA Black Box Warning for Breast Implants (2020)","citation":"FDA Order (2020)","requirements":"Black box warning on labeling. Patient decision checklist required. MRI screening recommendation for silicone every 5-6 years. Allergan Biocell textured recalled 2019.","compliance_status":null,"effective_date":"2020-10-27","enforcing_agency":"FDA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Explanted implants: medical waste per surgical facility protocols.","hazardous_waste":false,"expected_lifespan":"10-15_years"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-org-000668","name":"D4 (tetramethylcyclotetrasiloxane)","role":"silicone_gel","concentration_pct":"100 of fill"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000668","compound_name":null,"role":"silicone_gel","typical_concentration":"100% of fill"}],"identifiers":{"common_names":["breast implant (silicone gel bleed, bia-alcl, fda black box 2020)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"3M","manufacturer":"3M","market_position":"mass_market","notable":"Safety and specialty product conglomerate"},{"brand":"Honeywell","manufacturer":"Honeywell","market_position":"mass_market","notable":"Safety equipment and technology"},{"brand":"DuPont","manufacturer":"DuPont","market_position":"professional","notable":"Chemical and safety products"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA Black Box Warning for Breast Implants (2020) (FDA Order (2020))","jurisdiction":"USA","year":2020,"citation":"FDA Order (2020)","id":"src_8b8a3dc7"},{"id":"src_001","type":"database","title":"PubChem Compound CID 10913","url":"https://pubchem.ncbi.nlm.nih.gov/compound/10913","accessed":"2026-03-12","notes":"Chemical identity, properties, safety data","inherited_from_compound":"hq-c-org-000668"},{"id":"src_002","type":"epa","title":"EPA CompTox Chemicals Dashboard — DTXSID1027184","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID1027184","accessed":"2026-03-12","notes":"Hazard, exposure, and toxicity data","inherited_from_compound":"hq-c-org-000668"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:24:01.146Z"}}